Kundvagn 0 varor $0.00
Generic Olumiant (Baricitinib)
Olumiant
Olumiant (Baricitinib) is an oral JAK inhibitor used to treat rheumatoid arthritis, alopecia areata, and certain COVID-19 complications. It helps reduce inflammation and suppresses overactive immune responses.
Välj Doser: 4mg
4mg
28tabletter
Olumiant $4703.99
$3919.99
$140.00 per piller
+ Gratis standard airmail leverans
+ Paketleveransföretag försäkring
+ Nästa order 10% rabatt
LäGG TILL I KUNDVAGN
spara: $140.00
4mg
14tabletter
Olumiant $2385.59
$1987.99
$142.00 per piller
+ Gratis standard airmail leverans
+ Paketleveransföretag försäkring
+ Nästa order 10% rabatt
LäGG TILL I KUNDVAGN
spara: $42.00
4mg
7tabletter
Olumiant $1217.99
$1014.99
$145.00 per piller
+ Gratis standard airmail leverans
+ Paketleveransföretag försäkring
+ Nästa order 10% rabatt
LäGG TILL I KUNDVAGN
spara: $0.00
Ditt beställning kommer att förpackas trygg och säker och skickas inom 24 timmar. Det är precis hur ditt paket kommer att se ut (bilder av en verklig fraktpost). Den har en storlek och en titt på en vanlig privat brev (9.4x4.3x0.3 inches eller 24x11x0.7cm) och det avslöjar inte dess innehåll
Land Fraktsätt Leveranstider Pris  
Leverans 14-21 dagar 10$ Spårning # tillgängligt i 4 dagar
Leverans 9-14 dagar 30$ Spårning # tillgängligt i 2 dagar
Sändning över hela världen Sekretess och anonymitet garanti
Trygg och säker Diskreta söker paket
Avsändandet beställningar inom 24 timmar 100% framgång leverans
Kundbrev Produktbeskrivning
Det inte finns någon omdömet för denna produkt för närvarande men du vara först att skriva lägger till ellerman kan läsa mer i Kundreferenser sida om relaterade produkter.
Lägg Recension

Common use

Olumiant is a prescription medication used to treat moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other treatments. It is also approved for severe alopecia areata and COVID-19-related inflammation in certain hospitalized patients. The active ingredient, Baricitinib, is a Janus kinase (JAK) inhibitor that works by reducing inflammation and regulating the immune system. Olumiant helps relieve symptoms like joint pain, swelling, and stiffness, improving quality of life.

Dosage and direction

The typical dosage of Olumiant is 2 mg once daily, taken by mouth with or without food. In some cases, a 1 mg or 4 mg dose may be prescribed depending on the patient’s condition and tolerance. The tablet should be swallowed whole with water and taken at the same time each day. Dosage adjustments may be necessary in patients with kidney or liver impairment.

Precautions

Before using Olumiant, inform your doctor if you have a history of infections, tuberculosis, blood clots, liver or kidney disease, or cancer. Regular monitoring through blood tests may be required to check liver enzymes, cholesterol levels, and white blood cell counts. Avoid live vaccines during treatment. Olumiant may weaken the immune system, increasing the risk of infections.

Contraindications

Olumiant is contraindicated in patients with known hypersensitivity to Baricitinib or any of its components. It should not be used in patients with severe active infections, such as tuberculosis or sepsis. The medication is not recommended during pregnancy unless clearly necessary. Caution is advised in patients with a history of blood clots or cardiovascular events.

Possible side effect

Common side effects include upper respiratory tract infections, nausea, headache, and elevated cholesterol levels. Some patients may experience changes in liver enzymes, reduced white blood cell counts, or urinary tract infections. Rare but serious side effects include blood clots, serious infections, and increased risk of certain cancers. Seek medical attention if you experience chest pain, shortness of breath, or unusual bruising.

Drug interaction

Olumiant may interact with other medications that affect the immune system, such as biologic DMARDs, immunosuppressants, or strong CYP3A4 inhibitors/inducers. Concurrent use with certain antiviral or antifungal agents may alter its effect. Inform your healthcare provider of all medications and supplements you are taking. Drug interactions may necessitate dosage changes or close monitoring.

Missed dose

If you miss a dose of Olumiant, take it as soon as you remember. If it’s almost time for the next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once to make up for a missed one. Consistency is important for maintaining treatment effectiveness.

Overdose

In case of an overdose, seek immediate medical attention. Symptoms of overdose may include nausea, dizziness, or increased susceptibility to infection. There is no specific antidote for Baricitinib overdose. Treatment will typically involve supportive care and monitoring.

Storage

Store Olumiant at room temperature (15–30°C / 59–86°F), away from moisture, heat, and light. Keep the tablets in their original container with the lid tightly closed. Do not use after the expiration date printed on the package. Keep out of reach of children and pets.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Kundbrev
Peter
Jag är nöjd med mina produkter, onlinechatten var verkligen användbar , fick svar på alla mina frågor. Jag har absolut inget att gnälla över.
läs mer»
Sussie
Jag gillar priserna på Viagra för kvinnor som ni säljer, då jag använder den regelbundet sparar jag en hel del på att handla den hos er i jämförelse med andra nätapotek.
läs mer»
Nyheter
ADHD drugs have wider life benefits, study suggests
A study has linked ADHD drugs to reduced substance misuse, suicide, transport accidents and criminality.
UK cases of mosquito-borne virus more than double
More than 70 cases of the chikungunya virus were reported in the UK in the first six months of this year.
Survival rates for most deadly cancers making little progress, experts warn
Half of people with cancer survive but lack of progress for some forms of disease is worrying experts.
Driving theory test to include CPR first aid questions
Experts hope to boost cardiac arrest survival rates, with 2.4 million people sitting the test each year.
Leverans Alternativ